Strides Pharma Science acquires USFDA approved manufacturing facility in US

SourceBusiness Line
Date Published08/27/2019
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Strides Pharma Inc
Parent companyStrides Pharma Science Ltd
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2019
Year reshoring implemented or to be implemented:2019
Capital investment ($):10
Country(ies) from which reshored:India
City reshored to:Riviera Beach
State(s) reshored to:FL
If relevant, work nearshored to:-
Product(s) reshoredpharma
What domestic positive factors made reshoring more attractive?Automation/technology, Eco-system synergies, Under-utilized capacity
Find Reshoring Articles